FRIDAY, Jan. 28, 2022 (HealthDay News) -- For patients with rheumatoid arthritis aged 50 years or older with one or more additional cardiovascular risk factors, increased risks for major adverse cardiovascular events (MACE) and cancer are seen with tofacitinib compared with a tumor necrosis factor (TNF) inhibitor, according to a study published in the Jan. 27 issue of the New England Journal of Medicine.

FRIDAY, Jan. 28, 2022 (HealthDay News) -- Hospitalized COVID-19 patients receiving no oxygen or low-flow oxygen were more likely to achieve clinical improvement within 28 days if they were treated with remdesivir, according to a study published online Dec. 15 in Clinical Infectious Diseases.

FRIDAY, Jan. 28, 2022 (HealthDay News) -- Diabetic foot ulcer episodes are associated with an increased likelihood of all-cause inpatient admissions and death compared with periods after ulcer healing, according to a study published online Jan. 18 in Diabetes Research and Clinical Practice.

FRIDAY, Jan. 28, 2022 (HealthDay News) -- A total of 4.95 million deaths associated with bacterial antimicrobial resistance (AMR) were estimated in 2019, including 1.27 million deaths attributable to bacterial AMR, according to a study published online Jan. 19 in The Lancet.